MAPT and Alzheimer disease: Immunohistochemical analysis for APP, Aβ, tau and p-tau in the hippocampal CA1 regions of mice was performed in vitro at 4 months and 2 years after TBI due to its higher sensitivity for detecting weak to moderate pathological changes of AD compared with the in vivo PET assessment.